Epilepsy surgery, Functional MRI, Pre-op lateralization, Electroencephalogram, Emblozation This test is named after John A. Wada, the neurologist who first described it. The Wada test is a physiologic and neuropsychological test whereby one part of the brain is chemically suppressed by superselectively injecting a short-acting anesthetic substance (such as sodium amobarbital, sodium methohexital, or propofol) into a specific feeding artery. Complete neuropsychological evaluation is performed prior to and after injecting the anesthetic. The test is usually used prior to performing epilepsy surgery for language and memory lateralization testing and to guide the surgeon regarding the potential loss of language or memory after resection. In this scenario, the drug is injected selectively into the internal carotid artery. Superselective cerebral or spinal artery branch Wada testing, with or without electroencephalogram (EEG) and evoked potential testing, can also be performed during arteriovenous malformation embolization. Functional magnetic resonance imaging (MRI) is increasingly considered a less invasive and cost-effective option for language lateralization, especially in left-lateralization, proceeding with Wada testing for atypical language dominance. Multiple Sclerosis, MRI T2 hyperintensities, Dawson fingers, white matter disease, demyelination Magnetic resonance imaging (MRI) is the most sensitive imaging modality used for both diagnosis and surveillance in multiple sclerosis. Lesions seen on MRI represent underlying demyelination. Lesions within the brain typically involve the white matter tracts but can also involve portions of the gray matter. Characteristic lesion locations: Lesion shape: Patterns of enhancement seen on MRI:
W
Wada testing
Keywords
White Matter Tract Lesion in Multiple Sclerosis—Radiographic Features
Keywords